Skip to main content
CLNN
NASDAQ Life Sciences

10% Owner Sells Over $494K in Clene Inc. Stock Amidst Going Concern Doubts

Analysis by Wiseek.aiReviewed by Editorial Team
Sentiment info
Negative
Importance info
7
Price
$4.93
Mkt Cap
$58.067M
52W Low
$2.28
52W High
$13.5
Market data snapshot near publication time

summarizeSummary

Ugwumba Chidozie, a 10% owner of Clene Inc. (CLNN), sold 100,997 shares totaling $494,012 in open market transactions, continuing a pattern of insider distribution.


check_boxKey Events

  • Significant Insider Sale

    Ugwumba Chidozie, a 10% owner, sold 100,997 shares of Clene Inc. common stock for a total of $494,012.18 in open market transactions.

  • Follows Prior Intent to Sell

    These sales occurred between March 27-31, 2026, following a Form 144 filed on March 24, 2026, by Symbiosis II LLC, indicating an intent to sell 82,212 shares.

  • Context of Going Concern Doubt

    The sale takes place shortly after the company's 10-K filing on March 17, 2026, which expressed substantial doubt about its ability to continue as a going concern.


auto_awesomeAnalysis

This significant sale by a 10% owner, Ugwumba Chidozie (via SymBiosis II, LLC), represents a notable distribution of shares. The transactions occurred between March 27 and March 31, 2026, following a Form 144 filing on March 24, 2026, which indicated an intent to sell. While 10% owner sales are often for portfolio rebalancing, this transaction occurs in the context of Clene Inc.'s recent 10-K, which raised substantial doubt about its ability to continue as a going concern. This ongoing insider selling, totaling over $494,000, could be interpreted negatively by investors, especially given the company's financial uncertainties.

At the time of this filing, CLNN was trading at $4.93 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $58.1M. The 52-week trading range was $2.28 to $13.50. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed CLNN - Latest Insights

CLNN
Apr 22, 2026, 5:55 PM EDT
Filing Type: 4
Importance Score:
7
CLNN
Apr 17, 2026, 8:17 PM EDT
Filing Type: 4
Importance Score:
7
CLNN
Apr 15, 2026, 4:05 PM EDT
Filing Type: 144
Importance Score:
8
CLNN
Apr 10, 2026, 4:06 PM EDT
Filing Type: DEFA14A
Importance Score:
8
CLNN
Apr 10, 2026, 4:05 PM EDT
Filing Type: DEF 14A
Importance Score:
8
CLNN
Mar 31, 2026, 5:05 PM EDT
Filing Type: 144
Importance Score:
7
CLNN
Mar 31, 2026, 4:35 PM EDT
Filing Type: 4
Importance Score:
7
CLNN
Mar 24, 2026, 4:36 PM EDT
Filing Type: 144
Importance Score:
8
CLNN
Mar 17, 2026, 7:00 AM EDT
Filing Type: 10-K
Importance Score:
9
CLNN
Mar 16, 2026, 6:15 PM EDT
Filing Type: 8-K
Importance Score:
8